Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Brain Activity and Hormones Study Provides Clues on Facial Preferences

By LabMedica International staff writers
Posted on 10 Dec 2008
Scientists have long known that women's preferences for masculine men change throughout their menstrual cycles. More...
A new brain imaging study is the first to demonstrate differences in brain activity as women considered masculinized and feminized male faces and whether the individual could be a potential sexual partner.

The researchers, from Indiana University's Kinsey Institute (Bloomington, USA), identified regions of the brain that responded more strongly to masculine faces and demonstrated that differences between masculinized and feminized faces appeared strongest when the women were closer to ovulating.

The study, published in November 2008 in the online issue of the journal Evolution and Human Behavior (the print version is slated for January 2009), sheds light on the link between women's hormone levels and their brain responses to masculinized versus feminized male faces, possibly providing clues into female mate preferences. The study points towards enhancements of both sensory discrimination and risk processing around ovulation in response to masculine faces as possible mediators of women's mate preferences.

"One area of the brain in which we observed a difference in activation in response to masculinized versus feminized faces--specifically during the follicular phase--was the anterior cingulate cortex, which is a region involved in decision-making and the evaluation of potential reward and risk,” said neuroscientist Dr. Heather Rupp, research fellow at the Kinsey Institute for Research in Sex, Gender, and Reproduction. "Activation in this region has been previously reported to correlate with ‘high risk' nonsocial choices, specifically monetary risk, so it is interesting that it is observed to be more active in response to masculinized male faces, who may be both riskier but more rewarding to women.”

Previous studies have shown that women's sexual preference for facial characteristics vary depending on their menstrual phase. These fluctuating preferences are believed to reflect evolutionarily founded changes in women's reproductive priorities. Around the time of ovulation women prefer more masculinized faces--faces with features that indicate high levels of testosterone. These facial cues predict high genetic quality in the male because only such males can afford the immune-compromising effects of testosterone.

Testosterone may be costly for the males' mates as well because high testosterone levels also are associated with high rates of offspring abandonment. Around the time of ovulation, a female's preference apparently shifts from avoiding negligent parenting to acquiring the best genes for her offspring. At other points during the cycle, women will prefer more feminized male faces, as they might signal a higher willingness of the males to invest in offspring.

Dr. Rupp and her coworkers began to examine the link between hormone levels and brain responses to masculinized versus feminized male faces. Images of 56 male faces were masculinized and feminized using standard computer-morphing software. Twelve heterosexual women, averaging about 25 years old, were tested during the follicular phase, which is closer to ovulation and higher fertility time, and the luteal phases of their menstrual cycles. Before each test session, their blood was collected for hormone analyses. While brain activity was measured using functional magnetic resonance imaging (fMRI), women viewed the masculinized and feminized male faces, indicating their interest in the man depicted as a potential sexual partner.

The researchers found differences in brain regions related to face perception, reward processing, and decision-making, that responded more strongly to masculinized than feminized faces, suggesting that "neural activation in response to face stimuli is sensitive to facial masculinization, even in the absence of differences in subjective ratings.” Differences between masculinized and feminized faces appeared strongest during the follicular phase, closer to ovulation.

Related Links:

Indiana University's Kinsey Institute



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.